PhaseBio Pharmaceuticals, Inc.

PhaseBio Pharmaceuticals, Inc.verified

PHASQ

Price:

$0.000001

Market Cap:

$0

PhaseBio Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel for cardiovascular diseases. Its lead product candidate is bentracimab (PB2452), a reversal agent for the antiplatelet drug ticagrelor that is in Phase III clinical trial for patients with uncontrolled major or life-threatening bleeding events or in patients requiring urgent or an invasive procedure. The company is also developing PB1046, a vasoactive intestinal peptide analogue for the treatment of pulmonary arterial hypertension; and PB6440 for the treatment of resistant hypertension. The company has a co-development agreement with SFJ Pharmaceuticals X, Ltd...[Read more]

Industry

Biotechnology

IPO Date

2018-10-18

Stock Exchange

PNK

Ticker

PHASQ

The Enterprise Value as of November 2024 (TTM) for PhaseBio Pharmaceuticals, Inc. (PHASQ) is -33955000.00

According to PhaseBio Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -33955000.00. This represents a change of -149.58% compared to the average of 68.49M of the last 4 quarters.

PhaseBio Pharmaceuticals, Inc. (PHASQ) Historical Enterprise Value (quarterly & annually)

How has PHASQ Enterprise Value performed in the past?

The mean historical Enterprise Value of PhaseBio Pharmaceuticals, Inc. over the last ten years is 52.09M. The current -33955000.00 Enterprise Value has changed -6619.11% with respect to the historical average. Over the past ten years (40 quarters), PHASQ's Enterprise Value was at its highest in in the June 2019 quarter at 307.06M. The Enterprise Value was at its lowest in in the September 2017 quarter at 0.

Quarterly (TTM)
Annual

Average

52.09M

Median

58.29M

Minimum

-37138358.42

Maximum

108.66M

PhaseBio Pharmaceuticals, Inc. (PHASQ) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of PhaseBio Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 0.15%

Maximum Annual Enterprise Value = 108.66M

Minimum Annual Increase = -392.59%

Minimum Annual Enterprise Value = -37138358.42

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202142.77M-47.60%
202081.64M-24.87%
2019108.66M-392.59%
2018-37138358.42-163.67%
201758.33M0.15%

PhaseBio Pharmaceuticals, Inc. (PHASQ) Average Enterprise Value

How has PHASQ Enterprise Value performed in the past?

The current Enterprise Value of PhaseBio Pharmaceuticals, Inc. (PHASQ) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

77.69M

5-year avg

50.85M

10-year avg

52.09M

PhaseBio Pharmaceuticals, Inc. (PHASQ) Enterprise Value vs. Peers

How is PHASQ’s Enterprise Value compared to its peers?

PhaseBio Pharmaceuticals, Inc.’s Enterprise Value is less than Ceapro Inc. (16.01M), less than Oncotelic Therapeutics, Inc. (25.41M), less than Processa Pharmaceuticals, Inc. (15.28K), less than Kaleido Biosciences, Inc. (4.26K),

CompanyEnterprise ValueMarket cap
16.01M$13.31M
25.41M$12.63M
15.28K$2.81M
4.26K$4.26K

Build a custom stock screener for PhaseBio Pharmaceuticals, Inc. (PHASQ) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like PhaseBio Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

PhaseBio Pharmaceuticals, Inc. (PHASQ) and other stocks custom spreadsheet templates

The easiest way to analyze a company like PhaseBio Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is PhaseBio Pharmaceuticals, Inc.'s Enterprise Value?

What is the highest Enterprise Value for PhaseBio Pharmaceuticals, Inc. (PHASQ)?

What is the 3-year average Enterprise Value for PhaseBio Pharmaceuticals, Inc. (PHASQ)?

What is the 5-year average Enterprise Value for PhaseBio Pharmaceuticals, Inc. (PHASQ)?

How does the current Enterprise Value for PhaseBio Pharmaceuticals, Inc. (PHASQ) compare to its historical average?